Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia [Phase 2]
A Phase 2 trial evaluated silodosin 8 mg daily for nocturia in men with benign prostatic hyperplasia, with results posted after study comple…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia
This completed trial evaluated early versus delayed 5-alpha reductase inhibitor therapy in men with benign prostatic hyperplasia. Results we…
-
CLINICAL_TRIALS research · 2012-02-29Clinical Trial Update: Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
Clinical trial update analyzing treatment patterns and outcomes for benign prostatic hyperplasia using Marketscan data; results were posted …
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Changes of Upper and Lower Limb Blood Flow and Vascular Resistance in Hyperbaric Spinal Anesthesia for Transurethral Resection of the Prostate (TURP) Using Duplex Ultrasonography: Comparison of Normotensive and Hypertensive Patients
A completed clinical trial compared normotensive and hypertensive patients undergoing TURP under hyperbaric spinal anesthesia, assessing upp…
-
FDA approval · 2012-01-17FDA Approved: ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s alfuzosin hydrochloride extended-release as an Original Application, providing a generic option for treati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia [Phase 3]
A Phase 3 study evaluating tadalafil for Benign Prostatic Hyperplasia has completed. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia [Phase 3]
A Phase 3 trial evaluating MCS for lower urinary tract symptoms associated with benign prostatic hyperplasia has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
The study reports that consistent use of 5-alpha reductase inhibitors in benign prostatic hyperplasia is associated with clinical benefits. …
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg [NA]
This clinical trial update evaluates the clinical effect and safety of increasing tamsulosin from 0.2 mg to 0.4 mg in patients with LUTS/BPH…
-
FDA approval · 2011-10-31FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for tamsulosin hydrochloride submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
A post-marketing surveillance study evaluating doxazosin mesylate GITS in Filipino patients with benign prostatic hyperplasia has completed …
-
FDA approval · 2011-10-27FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Tamsulosin Hydrochloride from Sandoz Inc, authorizing its generic product for the treatment of b…
-
FDA approval · 2011-10-17FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (EXELAN PHARMACEUTICALS, INC.)
FDA approved a supplemental application for tamsulosin hydrochloride from Exelan Pharmaceuticals, indicating approval of a generic product.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
A completed clinical trial conducted at University Hospital, Grenoble, searched for protein profiles of fast-developing prostate cancer lesi…
-
FDA approval · 2011-09-27FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-09-27FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a Finasteride product manufactured by Aurobindo Pharma Limited, expanding access to a generi…
-
FDA approval · 2011-09-27FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approved a supplemental application for finasteride from Accord Healthcare, Inc.
-
FDA approval · 2011-08-29FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Tamsulosin Hydrochloride from Zydus Lifesciences Limited, authorizing changes under an already a…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fed Conditions [Phase 1]
Torrent Pharmaceuticals completed a Phase 1 bioequivalence study of Alfuzosin extended-release tablets in healthy volunteers under fed condi…
-
FDA approval · 2011-08-25FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-08-11FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for Finasteride from Dr. Reddy's Laboratories Limited, granting approval for the generic product…
-
FDA approval · 2011-08-03FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA granted a supplemental approval for Finasteride from Dr. Reddy's Laboratories Limited, resulting in changes to the product labeling unde…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) [Phase 1]
Phase 1 dose-response study of VA106483 in men with nocturia and benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH) [NA]
Clinical trial update evaluating the effects of tamsulosin 0.4 mg on clinical outcomes in Korean men with severe symptomatic benign prostati…
-
FDA approval · 2011-07-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride submitted by Teva Pharmaceuticals USA, updating the product’s labeling.